4.3 Article

Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab

Journal

LEUKEMIA & LYMPHOMA
Volume 56, Issue 6, Pages 1659-1664

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2014.963075

Keywords

Lymphoma and Hodgkin disease; chemotherapeutic approaches; antibody-based immunotherapy

Ask authors/readers for more resources

Rituximab is a monoclonal anti-CD20 antibody that is standard of care for treatment of B-cell non-Hodgkin lymphoma (NHL). The purpose of this study was to quantify the incidence of rituximab (R)-related interstitial pneumonitis (IP) in patients with NHL receiving immunochemotherapy. All patients with NHL who received cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP), cyclophosphamide, vincristine and prednisone (CVP), R-CHOP or R-CVP in Princess Margaret Hospital between June 1998 and August 2009 were retrospectively reviewed. We compared cohorts of patients who did and did not receive R and documented the incidence of IP during and/or post-treatment. In total 560 patients were included in this analysis.The rate of IP in the entire cohort was 2.9% (16/560) with a trend toward a higher rate in the R group (3.95% vs. 1.3% [odds ratio 3.1,0.84-17.27, p = 0.074]). Baseline pulmonary computed tomography abnormalities in patients with lymphoma are relatively common. The addition of R to chemotherapy does not significantly increase the risk of symptomatic chemotherapy-related IR

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medical Informatics

Exploring the relationship between patients' information preference style and knowledge acquisition process in a computerized patient decision aid randomized controlled trial

Anna M. Sawka, Sharon Straus, Gary Rodin, Richard W. Tsang, James D. Brierley, Lorne Rotstein, Phillip Segal, Amiram Gafni, Shereen Ezzat, David P. Goldstein

BMC MEDICAL INFORMATICS AND DECISION MAKING (2015)

Article Hematology

Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults

Shane A. Gangatharan, Manjula Maganti, John G. Kuruvilla, Vishal Kukreti, Rodger E. Tiedemann, Mary K. Gospodarowicz, David C. Hodgson, Alex Sun, Richard W. Tsang, Melania Pintilie, Michael Crump

BRITISH JOURNAL OF HAEMATOLOGY (2015)

Article Oncology

Thyroid Cancer Patient Perceptions of Radioactive Iodine Treatment Choice: Follow-Up From a Decision-Aid Randomized Trial

Anna M. Sawka, Sharon Straus, Gary Rodin, Lineke Heus, James D. Brierley, Richard W. Tsang, Lorne Rotstein, Shereen Ezzat, Phillip Segal, Amiram Gafni, Kevin E. Thorpe, David P. Goldstein

CANCER (2015)

Article Oncology

Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group

Maja V. Maraldo, Bouthaina S. Dabaja, Andrea R. Filippi, Tim Illidge, Richard Tsang, Umberto Ricardi, Peter M. Petersen, Deborah A. Schut, John Garcia, Jayne Headley, Amy Parent, Benoit Guibord, Riccardo Ragona, Lena Specht

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)

Article Oncology

Thyroid cancer survivors' perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey

Jacqueline L. Bender, David Wiljer, Anna M. Sawka, Richard Tsang, Nour Alkazaz, James D. Brierley

SUPPORTIVE CARE IN CANCER (2016)

Letter Oncology

Concerns of low-risk thyroid cancer survivors

Anna M. Sawka, Richard W. Tsang, James D. Brierley, Lorne Rotstein, Phillip Segal, Shereen Ezzat, David P. Goldstein

ACTA ONCOLOGICA (2016)

Article Oncology

Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience

Lynn Million, Esther J. Yi, Frank Wu, Rie Von Eyben, Belinda A. Campbell, Bouthaina Dabaja, Richard W. Tsang, Andrea Ng, Lynn D. Wilson, Umberto Ricardi, Youlia Kirova, Richard T. Hoppe

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Letter Endocrinology & Metabolism

Unmet Information Needs of Low-Risk Thyroid Cancer Survivors

Anna M. Sawka, James D. Brierley, Richard W. Tsang, Lorne Rotstein, Shereen Ezzat, David P. Goldstein

THYROID (2016)

Article Oncology

Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction

Ezra Hahn, Haiyan Jiang, Angela Ng, Shaheena Bashir, Sameera Ahmed, Richard Tsang, Alexander Sun, Mary Gospodarowicz, David Hodgson

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Article Otorhinolaryngology

Patterns of regional recurrence in papillary thyroid cancer patients with lateral neck metastases undergoing neck dissection

Jason J. Xu, Eugene Yu, Caitlin McMullen, Jesse Pasternak, Jim Brierley, Richard Tsang, Han Zhang, Antoine Eskander, Lorne Rotstein, Anna M. Sawka, Ralph Gilbert, Jonathan Irish, Patrick Gullane, Dale Brown, John R. de Almeida, David P. Goldstein

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)

Article Oncology

Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma

Haowei (Linda) Sun, Eshetu G. Atenafu, Richard Tsang, Vishal Kukreti, Theodore K. Marras, Michael Crump, John Kuruvilla

LEUKEMIA & LYMPHOMA (2017)

Letter Biophysics

Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

Umberto Falcone, Haiyan Jiang, Shaheena Bashir, Richard Tsang, Vishal Kukreti, Armand Keating, Michael Crump, John Kuruvilla

BONE MARROW TRANSPLANTATION (2018)

Article Oncology

Strategic planning in an academic radiation medicine program

J. L. Hamilton, S. Foxcroft, E. Moyo, J. Cooke-Lauder, T. Spence, P. Zahedi, A. Bezjak, D. Jaffray, C. Lam, D. Letourneau, M. Milosevic, R. Tsang, R. Wong, F. F. Liu

CURRENT ONCOLOGY (2017)

Article Oncology

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)

B. S. Dabaja, A. D. Zelenetz, A. K. Ng, R. W. Tsang, S. Qi, P. K. Allen, D. Hodgson, U. Ricardi, R. T. Hoppe, R. Advani, P. M. Mauch, L. S. Constine, L. Specht, Y. Li, S. A. Terezakis, A. Wirth, G. Reinartz, H. T. Eich, B. M. P. Aleman, P. Barr, J. Yahalom

ANNALS OF ONCOLOGY (2017)

Article Oncology

Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy

H. Vulpe, J. Y. Y. Kwan, A. McNiven, J. D. Brierley, R. Tsang, B. Chan, D. P. Goldstein, L. W. Le, A. Hope, M. Giuliani

CURRENT ONCOLOGY (2017)

No Data Available